/WPHM

WPHM Stock - Winston Pharmaceuticals, Inc.

Q: What is the analyst price target for WPHM?

Analyst price target information is not currently available for WPHM.

Q: What is WPHM's market cap?

Market capitalization information is not currently available for WPHM.

Healthcare|Medical - Pharmaceuticals|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for WPHM

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2005

FY2006

FY2007

FY2008

FY2009

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-982.38

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2009	FY2008	FY2007	FY2006	FY2005
Revenue	$1.39M	$452,542	N/A	N/A	N/A
Gross Profit	$1.39M	$443,891	N/A	$-208,949	$-19,849
Gross Margin	99.4%	98.1%	N/A	N/A	N/A
Operating Income	$-2,741,232	$-5,234,271	$-214,982	$-425,645	$-217,910
Net Income	$-2,655,316	$-5,141,746	$-180,105	$-464,995	$-230,800
Net Margin	-190.4%	-1136.2%	N/A	N/A	N/A
EPS	$-0.04	$-0.10	$-0.08	$-0.80	$-0.40

Company Overview

Winston Pharmaceuticals, Inc., a pharmaceutical company, discovers, develops, and commercializes therapeutics for pain management. It focuses on pain indications, such as episodic cluster headache, chronic migraine headache, neuropathic pain syndromes, osteo-and rheumatoid arthritis, and pain and inflammation in inflammatory bowel disease, as well as niche indications. Winston Pharmaceuticals, Inc. was formerly known as Winston Laboratories, Inc. and changed its name to Winston Pharmaceuticals, Inc. in November 2008. The company was incorporated in 1998 and is headquartered in Vernon Hills, Illinois.

Visit Website

Frequently Asked Questions about WPHM

What is WPHM's current stock price?

Winston Pharmaceuticals, Inc. (WPHM) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for WPHM?

No analyst price targets are currently available for this stock.

What sector is Winston Pharmaceuticals, Inc. in?

Winston Pharmaceuticals, Inc. operates in the Healthcare sector, specifically within the Medical - Pharmaceuticals industry. The company is traded on the OTC exchange.

What is WPHM's market cap?

Winston Pharmaceuticals, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does WPHM pay dividends?

No, Winston Pharmaceuticals, Inc. does not currently pay a dividend to shareholders.